Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD

被引：0
|
作者：
Heidi Fassnacht-Riederle
Matthias Becker
Nicole Graf
Stephan Michels
机构：
[1] City Hospital Triemli,Department of Ophthalmology
[2] University of Heidelberg,Department of Ophthalmology
[3] Graf Biostatistics,undefined
[4] University of Zurich,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2014年 / 252卷
关键词：
Age-related macular degeneration; Aflibercept; Ranibizumab; Bevacizumab; Tolerance; Tachyphylaxis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1705 / 1709
页数：4
相关论文
共 50 条
  • [31] Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema REPLY
    Rahimy, Ehsan
    Shahlaee, Abtin
    Khan, M. Ali
    Ying, Gui-Shuang
    Maguire, Joseph I.
    Ho, Allen C.
    Regillo, Carl D.
    Hsu, Jason
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 168 : 291 - 292
  • [32] Combination Brachytherapy and Anti-VEGF Therapy for CNV in AMD
    Heier, J.
    PROCEEDINGS OF THE 7TH INTERNATIONAL SYMPOSIUM ON OCULAR PHARMACOLOGY AND THERAPEUTICS, 2008, : 31 - 32
  • [33] Association of fluid recurrence with visual maintenance following the loading phase in anti-VEGF therapy for neovascular AMD
    Waldstein, Sebastian M.
    Chong, Victor
    Larsen, Michael
    Warburton, James
    Weichselberger, Andreas
    Wright, Jnathan
    Schmidt-Erfurth, Ursula
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [34] VARIANTS IN THE APOE GENE ARE ASSOCIATED WITH IMPROVED TREATMENT OUTCOME FOLLOWING ANTI-VEGF THERAPY FOR NEOVASCULAR AMD
    Wickremasinghe, Sanj
    Lim, Jonathan
    Xie, Jing
    Chauhan, Devinder
    Robman, Luba
    Richardson, Andrea
    Hageman, Gregory
    Baird, Paul
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 38 : 11 - 11
  • [35] OCT-Leakage in neovascular AMD - identification and location of abnormal fluid and response to anti-VEGF therapy
    Farinha, Claudia
    Santos, Torcato
    Santos, Ana Rita
    Lopes, Marta
    Alves, Dalila Gil
    Silva, Rufino
    Cunha-Vaz, Jose G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [36] Lens Capsule Biodegradable Lipid Implant for Sustained-Release Anti-VEGF Therapy of Neovascular AMD
    Molokhia, Sarah
    Burr, Randon M.
    Flood, Maggie
    Vallrath, Moritz
    Winter, Gerhard
    Ambati, Balamurali Krishna
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [37] Anti-VEGF intervention in neovascular AMD: benefits and risks restated as natural frequencies
    Clearkin, Louis
    Ramasamy, Balasubramanian
    Wason, James
    Tiew, Stephenie
    BMJ OPEN OPHTHALMOLOGY, 2019, 4 (01):
  • [38] Is Exudative Neovascular AMD a Chronic Disease? Analysis of Long-term Progression under Anti-VEGF Therapy
    Gunnemann, Marie-Louise
    Ziegler, Martin
    Book, Marius
    Gunnemann, Frederic
    Rothaus, Kai
    Spital, Georg
    Gutfleisch, Matthias
    Lange, Clemens
    Lommatzsch, Albrecht Peter
    Pauleikhoff, Daniel
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2024, 241 (12) : 1335 - 1340
  • [39] Anti-VEGF for neovascular ARMD: visual improvement as the goal of therapy?
    Bopp, Silvia
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (10) : 1259 - 1260
  • [40] Prediction of Anti-VEGF Treatment Requirements in Neovascular AMD Using a Machine Learning Approach
    Bogunovic, Hrvoje
    Waldstein, Sebastian M.
    Schlegl, Thomas
    Langs, Georg
    Sadeghipour, Amir
    Liu, Xuhui
    Gerendas, Bianca S.
    Osborne, Aaron
    Schmidt-Erfurth, Ursula
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (07) : 3240 - 3248
12345